Botswana’s ARV Program has been hailed as one of the successful treatments around the world, that have been running for more than a decade. Given the number of people living quality lives on treatment for a long time, it was imperative to ensure that the treatment program does not encounter resistance strains, to the current robust ARVs in the country. In an ongoing effort to strengthen Botswana's role in HIV drug resistance surveillance, WHO expert from Geneva, Dr.

Ethiopia conducted a polio vaccination campaign in five regions (Afar, Amhara, Gambella, Addis Ababa, and Sheger City of Oromia Region) with type 2 novel oral polio vaccine (nOPV2) targeting over 5.6 million aged below five years aiming to prevent transmission & circulation of variant poliovirus outbreaks. The campaign was officially launched by the Ministry of Health (MoH), Ethiopian Public Health Institute (EPHI), World Health Organization (WHO) and other GPEI polio partners in Semera, Afar.

The Ethiopian Public Health Institute (EPHI), with technical and financial support of partners including WHO and UNICEF, conducted a measles outbreak response vaccination campaign in four outbreaks affected regions of Amhara, Gambella, Oromia and South Ethiopia. The national cumulative administrative coverage showed that a total of 1,707,039 children under ten years (from 6 months - 10 years) were vaccinated during this measles reactive campaign.

Juba, 11 November 2024: A nationwide campaign aimed at vaccinating 3.3 million children from 0 to 59 months of age against polio launched in South Sudan using the novel Oral Polio Vaccine type 2. 

The campaign led by the Ministry of Health, with the support of the World Health Organization (WHO), UNICEF, and other partners, is in response to the confirmation of 12 cases of circulating variant poliovirus across eight counties in Western Equatoria, Central Equatoria, Upper Nile, and Jonglei States. 

Brazzaville – World Health Organization (WHO) and Africa Centres for Disease Control and Prevention (Africa CDC) experts gathered in Brazzaville this week with country representatives and partners to provide guidance for the development of targeted mpox vaccine preparedness and deployment plans to ensure that available doses are used efficiently.

Renowned for its excellent road infrastructure, Namibia has been a leader on the African continent in road safety, aligning its vision with the global decade of action on road safety. However, the high death toll on the Namibia roads is a stark reminder that good roads are not sufficient to ensuring road safety. A comprehensive strategy is essential, including ongoing enhancements in road and vehicle design, strengthening of laws and their enforcement, and ensuring timely emergency care for the injured.